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MATERIALS AND METHODS 
Synthetic chemistry 
All manipulations were performed using oven-dried glassware (130 °C for a minimum of 12 hours) and standard 
Schlenk techniques under an atmosphere of argon, unless otherwise stated.  
Solvents 
ACS- and HPLC-grade solvents were purchased from Fisher Chemical. Anhydrous tetrahydrofuran was 
obtained by filtration through a drying column and a deoyxgenation column on a Pure Process Technologies 
solvent system. High-purity water for PCR and HPLC was distilled after filtration through a deionizing column 
and organic removal column. Deuterated solvents were purchased from Cambridge Isotope Laboratories. 
Chromatographic materials  
Thin layer chromatography (TLC) was performed using EMD TLC plates pre-coated with 250 μm thickness 
silica gel 60 F254 and visualized by fluorescence quenching under UV light and staining with potassium 
permanganate or cerium ammonium molybdate. Preparative flash chromatography was performed using a 
Biotage Isolera automated chromatography instrument using columns hand-packed with silica gel (230–
400 mesh, Silicyle Inc.). 
Starting materials 
All compounds were used as received from commercial suppliers, unless otherwise stated.  
Analytical instrumentation 
HPLC-MS analysis for initial activity determination was performed on an Agilent 1290 UPLC-MS equipped with 
a C18 silica column (1.8 μm packing, 2.1×50 mm). HPLC-MS analysis of site-saturation mutagenesis libraries 
was performed on an Agilent 1260 Infinity HPLC with an Agilent 6120 quadrupole mass spectrometer. Reverse-
phase HPLC-UV analysis was performed with an Agilent 1200 series HPLC or an Agilent 1260 Series Infinity 
II HPLC using an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a Poroshell 120 
guard column (1.7 μm packing, 2.1×5 mm). Normal-phase HPLC-UV analysis for chiral separations was 
performed with a Hewlett Packard Series 1100 HPLC instrument using a Daicel Chiralcel OJ-H column, (5 μm 
packing, 4.6×250 mm) or a Daicel Chiralpak IB column (5 μm packing, 4.6×250 mm). 
NMR spectra were recorded on a Varian Unity/Inova 500 spectrometer operating at 500 MHz and 125 MHz for 
1H and 13C respectively, or a Bruker Avance 400 spectrometer operating at 400 MHz and 100 MHz for 1H and 
13C respectively. NMR data were analyzed in MestReNova (MestreLab Research). Chemical shifts are reported 
in ppm with the solvent resonance as the internal standard. For 1H NMR: CDCl3,  7.26. For 13C NMR: CDCl3, 
 77.16. Data are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, spt = septet, m = multiplet, 
br = broad; coupling constants in Hz; integration. 
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Biology and biocatalytic reactions 
Materials 
Oligonucleotides were purchased from IDT DNA. PCRs were run with Phusion® High-Fidelity PCR Kit (New 
England Biolabs). Gibson assembly mix1 is prepared with isothermal master mix in-house and enzymes T5 
exonuclease, Phusion® DNA polymerase, and Taq DNA ligase purchased from New England Biolabs.   
Cloning 
Plasmids encoding Pseudomonas savastanoi ethylene-forming enzyme (Uniprot ID P32021), Streptomyces sp. 
2-aminobutyric acid chlorinase (UniProt ID D0VX22), and Arabidopsis thaliana anthocyanidin synthase 
(UniProt ID Q96323), with the coding sequences codon-optimized for Escherichia coli were purchased from 
Twist Biosciences. Plasmids encoding Gluconobacter oxydans leucine dioxygenase (UniProt ID Q5FQD2), 
Streptomyces vinaceus arginine hydroxylase (UniProt ID Q6WZB0), and Streptomyces muensis leucine 
hydroxylase (UniProt ID A0A0E3URV8) were obtained from the laboratory of Prof. Hans Renata (Scripps 
Research Institute). The plasmid encoding Escherichia coli taurine dioxygenase (UniProt ID P37610) was 
obtained from the laboratory of Prof. Harry Gray (Caltech). All genes were encoded with a C-terminal His6-tag 
for purification and inserted between the NdeI and XhoI cut sites in the pET-22b(+) vector (Novagen).  
Plasmids were used to transform E. cloni BL21(DE3) cells (Lucigen) by electroporation. SOC medium (0.75 mL) 
was added and the cells were incubated at 37 °C for 45 minutes before being plated on Luria-Bertani medium 
(Research Products International) supplemented with ampicillin (100 μg mL-1, LB-amp) agar plates. 
Protein expression and purification 
Starter cultures of LB-amp were inoculated from a single E. coli colony on an agar plate harboring a plasmid 
encoding the protein of interest and grown overnight to stationary phase at 37 °C. Expression cultures of Terrific 
Broth (Research Products International) supplemented with ampicillin (100 mg L-1, TB-amp) were inoculated 
from the starter cultures (1% v/v) and shaken at 37 °C and 160 rpm in a Multitron Infors incubator. When the 
expression cultures reached OD600 ~ 0.8 (typically 2–3 hours), they were cooled on ice for 20 minutes. Protein 
expression was induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG, 0.5 mM). Cultures were 
incubated at 22 °C and 110 rpm overnight (16–24 hours). Cells were pelleted by centrifugation (5000×g, 
10 minutes).  
For reactions with whole cells, cell pellets were resuspended in MOPS buffer (20 mM pH 7.0) to OD600 30. For 
reactions with cell lysate, the whole cell suspensions were lysed by sonication (QSonica Q500 sonicator, 25% 
amplitude, 33% duty cycle, 3 minutes). The lysate was clarified by centrifugation (20,817×g, 10 minutes). 
For purification, cell pellets were frozen at −20 °C for at least 24 hours. Cells were resuspended in binding 
buffer (20 mM Tris∙HCl, 100 mM sodium chloride, 20 mM imidazole, pH 7.0, ~5 mL/g wet cells) and lysed by 
 
1 Gibson, D.G.; Young, L.; Chuang, R.-Y.; Venter, J.C.; Hutchison, C.A. III; Smith, H.O. Enzymatic assembly of DNA molecules up to 
several hundred kilobases. Nat. Methods 2009, 6, 343–345. 
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sonication (QSonica Q500 sonicator, 25% amplitude, 33% duty cycle, 4 minutes). The lysate was clarified by 
centrifugation (20,817 g, 10 minutes) followed by filtration (0.45 μm syringe filter). The protein was purified 
using an Äkta Purifier with a HisTrap HP column (GE Healthcare), eluting with a gradient of 20–500 mM 
imidazole. Fractions containing the protein of interest were pooled and dialyzed at 4 °C against MOPS buffer 
(20 mM pH 7.0) containing 1 mM EDTA (>100:1 v/v) (Spectrum Laboratories Spectra/Por 12–14 kD membrane) 
for four hours, then against MOPS buffer (20 mM pH 7.0) overnight (12–16 hours). The dialyzed protein was 
concentrated by centrifugal filtration (Amicon Ultra-15 10 kD MWCO) to a final concentration of 40–
100 mg mL−1. The concentrated protein was divided into aliquots (50–100 μL), flash-frozen on powdered dry 
ice, and stored at −80 °C. Protein concentration was determined by Bradford assay (Bio-Rad Quick Start 
Bradford). 
Site-saturation mutagenesis and library screening 
Site-saturation mutagenesis was performed using the 22-codon method2. Oligonucleotides including the three 
22-codon trick codons (NDT, VHG, TGG) and oligos within the ampicillin resistance cassette were used to 
amplify the plasmid in two pieces; oligo sequences are listed in Table S1. The two pieces were assembled via 
isothermal Gibson assembly (50 °C, 1 hour). The Gibson assembly product was used directly to transform E. 
cloni BL21(DE3) cells (Lucigen) by electroporation. SOC medium (0.75 mL) was added and the cells were 
incubated at 37 °C for 45 minutes before being plated on LB-amp agar plates. Single colonies from the agar 
plates were picked with sterile toothpicks and used to inoculate starter cultures (0.5 mL LB-amp) in 96 deep-
well plates. The starter culture plates were grown at 37 °C, 250 rpm, and 80% humidity in a Multitron Infors 
shaker overnight (14–16 hours). The starter cultures (50 μL) were used to inoculate expression cultures (1 mL 
TB-amp) in 96 deep-well plates. In parallel, glycerol stock plates were prepared for long-term storage by mixing 
starter culture (50 μL) with sterile glycerol (50% v/v, 50 μL) and frozen at −80 °C. The expression cultures were 
grown at 37 °C, 250 rpm, and 80% humidity for three hours, then cooled on ice for 20 minutes. Protein 
expression was induced by addition of IPTG (0.5 mM). Cultures were incubated at 22 °C and 220 rpm overnight 
(18–20 hours). Cells were pelleted (5000×g, 5 minutes) and the cell pellets were frozen at −20 °C for at least 
24 hours prior to use. 
Cells were resuspended in MOPS buffer (20 mM pH 7.0) containing 1 mM sodium acetate. Under air, ferrous 
ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration, prepared immediately before use), L-
ascorbic acid (40 mM in water, 10 μL, 1 mM final concentration, prepared immediately before use), styrene 
(400 mM in ethanol, 10 μL, 10 mM final concentration), and p-toluenesulfonyl azide (400 mM in ethanol, 10 μL, 
10 mM final concentration) were added to each well. The plates were sealed with foil covers and shaken at 
room temperature for two hours. To quench the reactions, acetonitrile (400 μL) was added and the reaction 
plate was shaken for an additional 30 minutes. Insoluble material was pelleted by centrifugation (6000×g, 
10 minutes) and 200 μL of the supernate was filtered through a 0.2 μm PTFE 96-well filter plate into a 96-well 
 
2 Kille, S.; Acevedo-Rocha, C.G.; Parra, L.P.; Zhang, Z.-G..; Opperman, D.J.; Reetz, M.T.; Acevedo, J.P. Reducing Codon Redundancy 
and Screening Effort of Combinatorial Protein Libraries Created by Saturation Mutagenesis. ACS Synth. Biol. 2013, 2, 83–92. 
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microplate (3000×g, 2 minutes). The microplate was sealed with a pierceable cover and analyzed via HPLC-
MS (Analytical instrumentation). 
Table S1. Oligonucleotides used for mutagenesis. Mutated codons are denoted here as NNN for simplicity; in 
practice they are a 12:9:1 ratio of NDT:VHG:TGG for site saturation or the appropriate single codon for site-
directed mutagenesis. 
Mutations 
relative to 
wild type Direction Sequence 
T97X Forward CCGACTTCCCCGAAATTTTCNNNGTCTGCAAAGATCTTTC 
T97X Reverse GAAAATTTCGGGGAAGTCGGGCTTTCCAGCAGTCACCTC 
R171X Forward GATGGATGGCACCACATGNNNGTGTTGCGTTTTCCGCC 
R171X Reverse CATGTGGTGCCATCCATCGCGGGTCAAATCTG 
R277X Forward GGTGAAACTTAATACACGTGAGNNNTTTGCTTGCGCGTACTTCCATGAGCCG 
R277X Reverse CACGTGTATTAAGTTTCACCTTATGCGGAGTGCTAAGTAACTGTCCCCCG 
F314X 
C317M 
Forward CACTATGGGGAACATTTCACGAACATGNNNATGCGTATGTATCCTGACCG 
F314X Reverse CATGTTCGTGAAATGTTCCCCATAGTGAATGCGCTCATTGGCC 
C317X Forward TCACGAACATGTTCATGCGTNNNTATCCTGACCGCATTACCACACAGC 
C317X Reverse CATGAACATGTTCGTGAAATGTTCCCCATAGTGAATGCGCTC 
Analytical-scale biocatalytic aziridination reactions 
Biocatalytic reactions were set up in 2-mL screw-cap vials (Agilent). Purified apoprotein (350 μL, 22.9 μM in 
20 mM MOPS pH 7.0, final concentration 20 μM) was added to the vial. Solutions of ferrous ammonium sulfate 
and L-ascorbic acid were prepared immediately prior to use. Reactions to be set up anaerobically were brought 
into a Coy vinyl anaerobic chamber (nitrogen atmosphere, 0–10 ppm oxygen). To each reaction was added in 
order ferrous ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration), sodium acetate or other 
additive (40 mM in water, 10 μL, 1 mM final concentration), and L-ascorbic acid (40 mM in water, 10 μL, 1 mM 
final concentration). Each reaction was then charged with styrene (400 mM in ethanol, 10 μL, 10 mM final 
concentration) immediately followed by p-toluenesulfonyl azide (400 mM in ethanol, 10 μL, 10 mM final 
concentration, 500 max. TTN). The reactions were sealed and shaken at room temperature for three hours 
unless otherwise noted. To quench the reactions, acetonitrile (350 μL) was added to each vial, followed by 
internal standard propiophenone (0.1% v/v in acetonitrile, 50 μL). The sample was transferred to a 1.7-mL 
Eppendorf tube, vortexed, and then centrifuged (20817×g, 5 minutes). 250 μL of the supernate was transferred 
to HPLC vial inserts for reverse-phase HPLC analysis. The remaining supernate was partially concentrated in 
vacuo to remove acetonitrile and ethanol. Cyclohexane (500 μL) was added to the resulting aqueous 
suspension. The mixture was thoroughly shaken and then centrifuged (20817×g, 5 minutes). 250 μL of the 
organic layer was transferred to HPLC vial inserts for normal-phase chiral HPLC analysis. 
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Analytical-scale biocatalytic C–H insertion reactions 
Biocatalytic reactions were set up in 2-mL screw-cap vials (Agilent). Purified apoprotein (360 μL, 22.2 μM in 
20 mM MOPS pH 7.0, final concentration 20 μM) was added to the vial. Solutions of ferrous ammonium sulfate 
and L-ascorbic acid were prepared immediately prior to use. Reactions to be set up anaerobically were brought 
into a Coy vinyl anaerobic chamber (nitrogen atmosphere, 0–10 ppm oxygen). To each reaction was added in 
order ferrous ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration), sodium acetate or other 
additive (40 mM in water, 10 μL, 1 mM final concentration), L-ascorbic acid (40 mM in water, 10 μL, 1 mM final 
concentration). Each reaction was then charged with 2-ethylbenzenesulfonyl azide (400 mM in ethanol, 10 μL, 
10 mM final concentration, 500 max. TTN). The reactions were sealed and shaken at room temperature for six 
hours unless otherwise noted. To quench the reactions, acetonitrile (350 μL) was added to each vial, followed 
by internal standard propiophenone (0.5% v/v in acetonitrile, 50 μL). The sample was transferred to a 1.7-mL 
Eppendorf tube, vortexed, and then centrifuged (20817×g, 5 minutes). 250 μL of the supernate was transferred 
to HPLC vial inserts for reverse-phase HPLC analysis. The remaining supernate was partially concentrated in 
vacuo to remove acetonitrile and ethanol. Hexanes (250 μL, HPLC grade) and ethyl acetate (250 μL, HPLC 
grade) were added. The resulting mixture was thoroughly shaken and then centrifuged (20817×g, 5 minutes). 
250 μL of the organic layer was transferred to HPLC vial inserts for normal-phase chiral HPLC analysis. 
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EXPERIMENTAL DATA 
Initial evaluation of α-ketoglutarate-dependent iron dioxygenases 
 
Reactions were performed as described above (Analytical-scale biocatalytic aziridination reactions) except 
enzyme concentrations were 50 μM, disodium α-ketoglutarate was used as the additive, and acetonitrile was 
used as the co-solvent. Activity was assayed by HPLC-MS (Analytical instrumentation). Activities are 
normalized to the negative control, bovine serum albumin. 
Table S2. Activities of α-KG-dependent iron enzyme towards aziridination to form 3. 
Enzyme Relative activity 
P. savastanoi ethylene-forming enzyme 12.0 
Streptomyces sp. 2-aminobutyric acid chlorinase 0.93 
A. thaliana anthocyanidin synthase 0.54 
G. oxydans leucine dioxygenase 1.11 
E. coli taurine dioxygenase 0.61 
S. vinaceus arginine hydroxylase 0.57 
S. muensis leucine hydroxylase 0.61 
Bovine serum albumin (negative control) 1.00 
 
Reaction condition controls 
Aziridination reaction 
 
Reactions were performed in triplicate as described above with acetate as additive (Analytical-scale biocatalytic 
aziridination reactions) except where noted. Yields given are the average of the triplicates. 
SUPPORTING INFORMATION  S9 
Table S3. Aziridination reaction controls with wild-type PsEFE. 
Deviation from standard conditions Aziridine yield (%) 
None 0.56% 
No iron 0.01% 
No ascorbate 0.50% 
No acetate 0.04% 
αKG instead of acetate 0.08% 
Succinate instead of acetate 0.11% 
N-oxalylglycine instead of acetate 0.64% 
 
Table S4. Aziridination reaction controls with PsEFE T97M R171L R277H F314M C317M 
Deviation from standard conditions Aziridine yield (%) 
None 23.8 
No iron 0.1 
No ascorbate 15.2 
No acetate 2.1 
α-Ketoglutarate instead of acetate 2.6 
N-oxalylglycine instead of acetate 2.4 
Aerobic 4.7 
Aerobic, no ascorbate 2.9 
 
C–H insertion reaction 
 
Reactions were performed in triplicate as described above (Analytical-scale biocatalytic C–H insertion 
reactions) with acetate as the additive, except where otherwise noted. Data shown are the average of the 
triplicates. 
Table S5. C–H insertion reaction controls (max. 500 TTN) 
Variant Additive TTN (5) 5/6 
Wild type Acetate 12.3 1.6 
R171V F314M C317M Acetate 313 24 
R171V F314M C317M None 24.6 0.9 
R171V F314M C317M α-Ketoglutarate 130 9.0 
R171V F314M C317M N-Oxalylglycine 447 105 
R171V R277H F314M C317M Acetate 243 32 
R171V R277H F314M C317M None 27.0 3.4 
R171V R277H F314M C317M α-Ketoglutarate 30.8 3.8 
R171V R277H F314M C317M N-Oxalylglycine 33.3 4.1 
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C–H insertion reaction with whole cells and cell lysate 
Reactions were performed in triplicate as described above (Analytical-scale biocatalytic C–H insertion 
reactions), except whole cell suspensions and cell lysates were used instead of purified protein solutions. Data 
shown are the average of the triplicates. Note that the chemoselectivities are generally much lower than with 
purified protein; this is presumably due to increased reduction by the cellular background. 
Table S6. C–H insertion with whole cells and lysate 
Variant Formulation Additive % Yield (5) 5/6 
VMM Whole cells None 36% 1.6 
VMM Whole cells Acetate 37% 1.7 
VMM Whole cells αKG 36% 1.6 
VMM Whole cells NOG 30% 1.6 
VMM Lysate None 76% 7.7 
VMM Lysate Acetate 72% 7.0 
VMM Lysate αKG 69% 6.3 
VMM Lysate NOG 90% 12.7 
VHMM Whole cells None 33% 3.5 
VHMM Whole cells Acetate 34% 3.7 
VHMM Whole cells αKG 33% 3.4 
VHMM Whole cells NOG 27% 3.1 
VHMM Lysate None 73% 15.8 
VHMM Lysate Acetate 75% 16.9 
VHMM Lysate αKG 73% 14.3 
VHMM Lysate NOG 77% 17.0 
SDS-PAGE of PsEFE variants 
Large-scale protein expression, lysis, and purification was carried out as described in the methods section 
(Protein expression and purification). Whole-cell samples were taken after resuspension, clarified lysate 
samples were taken following sonication and centrifugation, and purified protein samples were taken after 
HisTrap purification. These samples were mixed 1:1 with 2X Laemmli loading buffer (Bio-Rad Laboratories, 
Inc.) with added 2-mercaptoethanol. Samples were heated to 95 °C in a thermomixer block, briefly centrifuged, 
and loaded on an Any kD™ Mini-PROTEAN® TGX™ Precast Protein Gels (Bio-Rad Laboratories, Inc.). Gels 
were run at 150 V for 30–45 minutes. Gels were washed with water, then stained by microwaving the gels with 
Coomassie solution. Gels were destained with successive rounds of microwaving with water, followed by gentle 
shaking overnight in water. 
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Aziridination variant protein purification 
  
Figure S1. SDS-PAGE of PsEFE aziridination variant T97M R171L R277H F314M C317M (PsEFE MLHMM). 
The protein is shown from left to right as whole-cell sample, clarified lysate sample, and purified protein 
sample. Whole cells and lysates were diluted 25-fold; purified protein was diluted 50-fold (each dilution is 
prior to addition of 2X Laemmli loading dye). The ladder and sample were run on the same gel; unrelated 
protein samples were cropped out for image clarity. The SDS-PAGE image brightness was increased in 
Microsoft Word for image clarity and is not being used for quantitation. 
C–H insertion variant protein purification 
 
Figure S2. SDS-PAGE of PsEFE C–H insertion variants. Each protein is shown from left to right as whole-cell 
sample, clarified lysate sample, and purified protein sample. Whole cells and lysates were diluted 25-fold; 
purified protein was diluted 50-fold (each dilution is prior to addition of 2X Laemmli loading dye). Protein 1: 
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R171V F314M C317M, Protein 2: R171V R277H F314M C317M. Protein 3: T97M R171V R277H F314L 
C317M. The SDS-PAGE image brightness was increased in Microsoft Word for image clarity and is not being 
used for quantitation.  
Reaction time courses 
Aziridination time course 
A time course was run with PsEFE WT and PsEFE MLLHMM, a variant with one additional mutation (I186L) 
relative to PsEFE MLHMM with decreased activity and slightly increased enantioselectivity. Purified protein 
reactions were set up in triplicate both anaerobically and aerobically, as described in the methods section above 
(Analytical-scale biocatalytic aziridination reactions). Time points were taken at 15 minutes, 30 minutes, 1 hour, 
2 hours, 3 hours, 4 hours, and 8 hours, at which point those reactions were quenched by addition of acetonitrile 
(350 μL) and the internal standard propiophenone (1 μL mL-1 in acetonitrile, 50 μL).  
As we see in Figure S3, the reaction with wild-type PsEFE is essentially done by the 15 minute mark, while the 
yield with MLLHMM continues to increase until approximately 2 hours. The reaction appears to proceed for a 
longer time anaerobically than aerobically for PsEFE MLLHMM; the low activity and fast reaction completion 
for wild-type PsEFE makes such comparisons challenging. 
 
Figure S3. Aziridination time course. Time courses denoted “air” were set up aerobically; time courses 
denoted “Coy” were set up anaerobically. 
SUPPORTING INFORMATION  S13 
Evolved variant thermostability 
During our purified protein reactions, we do observe what is ostensibly protein precipitation over time. This 
visual observation, together with our time-course data, indicate that one possible reason for limited activity 
might be the protein’s stability to the reaction conditions over time. The thermostability of wild-type PsEFE has 
been measured with ITC3; not surprisingly, the protein is reported to have increased stability in the presence 
of iron and α-ketoglutarate. We used the thermal shift assay4 using SYPRO orange (Thermo Fisher Scientific). 
Thermal shift assay samples were prepared in triplicate anaerobically under similar conditions as described 
above (Reaction condition controls). To a PCR tube with purified PsEFE wild type or a PsEFE variant (stripped 
and dialyzed, 10–15 µM final concentration) was added (to a final concentration of 1.25 mM each) either: 
• ferrous ammonium sulfate 
• ferrous ammonium sulfate, L-ascorbic acid, and α-ketoglutarate 
• ferrous ammonium sulfate, L-ascorbic acid, and sodium acetate 
Following these additions, to each tube was added 5 µL SYPRO orange (25-fold diluted in water). The PCR 
tubes were sealed, brought out of the anaerobic chamber, and analyzed on an Stratagene Mx3005P qPCR 
machine (Agilent Technologies, Inc.). The temperature program ran from 25 °C to 99 °C, holding for 30 seconds 
per degree before measuring fluorescence on the SYPRO channel and increasing temperature. The melting 
temperature for a given temperature was taken as the maximum of the numerical first derivative, representing 
the inflection point of the protein’s melt curve.  
The data are presented in Figure S4. We can see that, even though beneficial mutations were only chosen 
based on activity and stereoselectivity, the protein’s stability improved from wild type to the final variants. We 
also see a significant enhancement in thermostability for early variants upon addition of α-ketoglutarate (noted 
as 2OG for 2-oxoglutarate), which is not observed in the later evolved variants. 
 
 
3 Li, M.; Martinez, S.; Hausinger, R. P.; Emerson, J. P. Thermodynamics of Iron(II) and Substrate Binding to the Ethylene-Forming 
Enzyme. Biochemistry 2018, 57, 5696-5705. 
4 Ericsson, U. B.; Hallberg, B. M.; DeTitta, G. T.; Dekker, N.; Nordlund, P. Thermofluor-based high-throughput stability optimization of 
proteins for structural studies. Anal. Biochem. 2006, 357, 289–298. 
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Figure S4. Thermostability of wild-type and evolved PsEFE variants for aziridination and intramolecular C-H 
insertion.  
Synthesis of sulfonyl azide substrates 
Safety statement 
Organic azides are potentially explosive compounds. We have not observed any problems in our handling of 
the compounds described, but care should be taken, especially on large scales. 
p-Toluenesulfonyl azide (2) 
 
Under air, p-toluenesulfonyl chloride (19.1 g, 100 mmol, 1.00 equiv.) was dissolved in acetone (200 mL) in a 
500 mL round-bottomed flask with a magnetic stir bar and cooled to 0 °C. A solution of sodium azide (9.75 g, 
150 mmol, 1.50 equiv.) in water (60 mL) was added dropwise over one hour with stirring. Once addition was 
complete, the reaction was allowed to warm to room temperature and stirred for 16 hours. The acetone was 
removed in vacuo, and the resulting mixture was extracted with diethyl ether (2×100 mL). The combined organic 
layers were washed with water (2×100 mL), saturated aqueous sodium bicarbonate (100 mL), and brine 
(100 mL), then dried over magnesium sulfate and concentrated in vacuo to afford the title compound as a 
colorless oil that solidified upon storage at −20 °C (19.1 g, 97%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.80 (d, J = 8.5 Hz, 2 H), 7.38 (d, J = 8.5 Hz, 2 H), 2.45 (s, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 146.3, 135.3, 130.3, 127.4, 21.7 
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2-Ethylbenzenesulfonyl chloride (S1)5 
 
Under argon, 1-bromo-2-ethylbenzene (2.07 mL, 2.78 g, 15.0 mmol, 1.00 equiv.) was dissolved in anhydrous 
tetrahydrofuran (30 mL) in a 100 mL round-bottomed flask with magnetic stirring and cooled to −40 °C. 
n‑Butyllithium (2.5 M solution in hexanes, 7.20 mL, 18.0 mmol, 1.20 equiv.) was added dropwise by syringe 
over two minutes. The reaction was stirred at −40 °C for thirty minutes, then sulfuryl chloride (1.82 mL, 3.04 g, 
22.5 mmol, 1.5 equiv.) was added dropwise by syringe over two minutes. The reaction was allowed to warm to 
room temperature and stirred for 16 hours. The reaction was cooled to 0 °C, then carefully quenched by the 
addition of ice-cold water (50 mL). The resulting mixture was extracted with diethyl ether (2×50 mL). The 
combined organic layers were dried over sodium sulfate and concentrated in vacuo. The residue was purified 
by flash column chromatography on silica (50 g), eluting with a gradient of 0 to 20% diethyl ether/hexanes, to 
afford the title compound as a slightly yellow oil (1.10 g, 36%). 
NMR Spectroscopy:  
1H NMR (400 MHz, CDCl3, 23 ºC, ): 8.07 (d, J = 8.1 Hz, 1 H), 7.66 (t, J = 7.5 Hz, 1 H), 7.49 (d, J = 
7.6 Hz, 1 H), 7.41 (t, J = 7.9 Hz, 1 H), 3.20 (q, J = 7.5 Hz, 2 H), 1.37 (t, J = 7.5 Hz, 3 H) 
2-Ethylbenzenesulfonyl azide (4)5 
 
Under air, 2-ethylbenzenesulfonyl chloride S1 (1.00 g, 4.89 mmol, 1.00 equiv.) was dissolved in acetone (8 mL) 
in a 20 mL scintillation vial with magnetic stirring and cooled to 0 °C. A solution of sodium azide (476 mg, 
7.33 mmol, 1.50 equiv.) in water (2.5 mL) was added dropwise over two minutes with stirring. Once addition 
was complete, the reaction was allowed to warm to room temperature and stirred for six hours. The acetone 
was removed in vacuo, and the resulting mixture was extracted with diethyl ether (2×15 mL). The combined 
organic layers were washed with water, saturated aqueous sodium bicarbonate, and brine (15 mL each), then 
dried over magnesium sulfate and concentrated in vacuo to afford the title compound as a yellow oil (1.01 g, 
98%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 8.01 (dd, J = 8.0, 1.3 Hz, 1 H), 7.62 (td, J = 7.6, 1.3 Hz, 1 H), 7.46 
 
5 Ichinose, M.; Suematsu, H.; Yasutomi, Y.; Nishioka, Y.; Uchida, T.; Katsuki, T. Enantioselective Intramolecular Benzylic C–H Bond 
Amination: Efficient Synthesis of Optically Active Benzosultams. Angew. Chem. Int. Ed. 2011, 50, 9884–9887. 
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(dd, J = 7.7, 0.7 Hz, 1 H), 7.37 (td, J = 8.0, 1.2 Hz, 1 H), 3.03 (q, J = 7.5 Hz, 2 H), 1.31 (t, J = 7.5 Hz, 
3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 144.5, 136.3, 134.9, 131.4, 129.4, 126.4, 26.1, 15.2 
Synthesis of authentic product standards 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
 
Under argon, chloramine-T trihydrate (4.23 g, 15.0 mmol, 1.00 equiv.) and iodine (381 mg, 1.50 mmol, 
0.100 equiv.) were dissolved in acetonitrile (100 mL). Styrene (3.45 mL, 3.13 g, 30.0 mmol, 2.00 equiv.) was 
added dropwise, and the reaction was stirred at room temperature for 18 hours. The reaction mixture was 
partitioned between water (50 mL) and dichloromethane (100 mL), and the layers were separated. The 
aqueous layer was extracted with dichloromethane (2×100 mL). The combined organic layers were 
concentrated in vacuo and the residue was purified by flash column chromatography on silica (100 g) eluting 
with hexanes/ethyl acetate (6:1 v/v) containing 1% triethylamine to afford the title compound as a colorless 
solid (3.55 g, 87%). 
NMR Spectroscopy: 
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.87 (d, J = 8.3 Hz, 2 H), 7.33 (d, J = 8.3 Hz, 2 H), 7.30–7.25 (m, 
3 H), 7.24–7.20 (m, 2 H), 3.78 (dd, J = 7.2, 4.5 Hz, 1 H), 2.99 (d, J = 7.2 Hz, 1 H), 2.44 (s, 3 H), 2.40 (d, 
J = 4.4 Hz, 1 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 144.8, 135.1, 135.0, 129.9, 128.7, 128.4, 128.1, 126.7, 41.2, 36.1, 
21.8 
3-Methylbenzo[d]isothiazole 1,1-dioxide (S2)6 
 
Under argon, saccharin (1.00 g, 5.46 mmol, 1.00 equiv.) was dissolved in anhydrous tetrahydrofuran (25 mL) 
in a 100 mL round-bottomed flask with magnetic stirring and cooled to 0 °C. Methylmagnesium bromide (3 M 
solution in diethyl ether, 4.00 mL, 12.0 mmol, 2.20 equiv.) was added dropwise by syringe over 10 minutes. 
 
6 Li, B.; Chen, J.; Zhang, Z.; Gridnev, I.Y., Zhang. W. Nickel-Catalyzed Asymmetric Hydrogenation of N-Sulfonyl Imines. Angew. Chem. 
Int. Ed. 2019, 58, 7329–7334. 
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After addition, the reaction was stirred at 0 °C for five minutes, then slowly warmed to room temperature and 
stirred at room temperature for 16 hours. The reaction was then cooled to 0 °C and carefully poured into ice-
cold hydrochloric acid (1 M, 30 mL). The resulting mixture was extracted with dichloromethane (2×50 mL). The 
combined organic layers were dried over sodium sulfate and concentrated in vacuo to afford the title compound 
as a colorless solid (crude yield 1.04 g, 105%) which was used in the next step without further purification. 
NMR Spectroscopy: 
1H NMR (400 MHz, CDCl3, 23 ºC, ): 7.94–7.90 (m, 1 H), 7.77–7.73 (m, 2 H), 7.71–7.67 (m, 1 H), 2.67 
(s, 3 H) 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
 
Under air, 3-methyl-[d]isothiazole 1,1-dioxide S2 (500 mg, 2.76 mmol, 1.00 equiv.) was dissolved in methanol 
(20 mL) in a 50 mL round-bottomed flask with magnetic stirring. Sodium borohydride (522 mg, 13.8 mmol, 
5.00 equiv.) was slowly added over two minutes. The reaction mixture bubbled vigorously and became warm 
to the touch. The reaction was stirred at room temperature for thirty minutes to ensure complete reaction. The 
reaction was cooled to 0 °C, then poured carefully into cold hydrochloric acid (2.5 M, 40 mL). The methanol 
was removed in vacuo and the resulting mixture was extracted with dichloromethane (3×25 mL). The combined 
organic layers were dried over sodium sulfate and concentrated in vacuo. The residue was purified by flash 
column chromatography on silica (25 g), eluting with a gradient of 10 to 60% ethyl acetate/hexanes to afford 
the title compound as a colorless solid (378 mg, 75%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.74 (d, J = 8.0 Hz, 1 H), 7.61 (td, J = 7.6, 1.0 Hz, 1 H), 7.50 (t, J = 
7.6 Hz, 1 H), 7.38 (d, J = 7.7 Hz, 1 H), 5.15 (br d, J = 4.8 Hz, 1 H), 4.78 (qd, J = 6.7, 4.8 Hz, 1 H), 1.59 
(d, J = 6.7 Hz, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 141.8, 135.4, 133.3, 129.2, 124.0, 121.2, 53.5, 21.5 
2-Ethylbenzenesulfonamide (6) 
 
Under air, 2-ethylbenzenesulfonyl chloride S1 (50.0 mg, 244 μmol, 1.00 equiv.) was dissolved in 
tetrahydrofuran (1 mL) in a 4 mL vial with magnetic stirring and cooled to 0 °C. Ammonia (28% w/v in water, 
149 μL, 2.44 mmol, 10.0 equiv.) was added dropwise over one minute. After stirring for five minutes, the 
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reaction mixture was partitioned between water and ethyl acetate (10 mL each). The layers were separated 
and the aqueous layer was extracted with ethyl acetate (2×10 mL). The combined organic layers were washed 
with brine (10 mL), dried over sodium sulfate, and concentrated in vacuo to afford the title compound as a 
colorless solid (41.8 mg, 92%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.99 (d, J = 8.0 Hz, 1 H), 7.51 (t, J = 7.5 Hz, 1 H), 7.39 (d, J = 7.6 Hz, 
1 H), 7.29 (t, J = 7.7 Hz, 1 H), 5.02 (br s, 2 H), 3.07 (q, J = 7.5 Hz, 2 H), 1.33 (t, J = 7.5 Hz, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ):143.0, 139.6, 133.1, 130.7, 128.3, 126.2, 26.1, 15.3 
 
HPLC analytical methods and calibration curves 
Aziridination reaction 
 
Samples for HPLC calibration curves were prepared as simulated reaction samples. To MOPS buffer (20 mM 
pH 7.0, 380 μL) was added a solution of the appropriate reaction product in acetonitrile (0–100 μM, 20 μL, final 
concentration 0–5 mM). To this sample was added the internal standard propiophenone (0.1% v/v in acetonitrile, 
50 μL) and acetonitrile (350 μL). The product concentration in the curves below corresponds to the 
concentration in the reaction mixture; the final analytical sample is two-fold diluted. 
Analysis was performed on an Agilent 1200 series HPLC with water/acetonitrile mobile phase (1 mL min-1 flow), 
with an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a Poroshell 120 guard 
column (1.7 μm packing, 2.1×5 mm), injecting 5 μL. Detection was at 230 nm (16 nm bandwidth). The gradient 
program and retention times are given in Table S7 and Table S8, respectively. 
Table S7. HLPC gradient program for aziridination analysis 
Time (minutes) % Acetonitrile 
0.00 20 
0.50 20 
1.00 40 
5.00 65 
5.50 95 
6.00 95 
6.01 20 
7.00 20 
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Table S8. HPLC retention times for aziridination analysis 
Compound Retention time (minutes) 
p-Toluenesulfonamide 0.58 
Propiophenone 2.24 
p-Toluenesulfonyl azide 2.81 
Styrene 3.01 
2-Phenyl-1-(p-toluenesulfonyl)aziridine 3.45 
 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (3) calibration curve 
 
p-Toluenesulfonamide (S3) calibration curve 
 
y = 1.5815x
R² = 0.9927
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5
P
ro
d
u
c
t/
s
ta
n
d
a
rd
 r
a
ti
o
Product concentration (mM)
y = 1.2648x
R² = 0.9992
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5
P
ro
d
u
c
t/
s
ta
n
d
a
rd
 r
a
ti
o
Product concentration (mM)
SUPPORTING INFORMATION  S20 
C–H insertion reaction 
 
Calibration curve samples were prepared as described above for the aziridination reaction, except the internal 
standard used was propiophenone (0.5% v/v in acetonitrile, 50 μL) and the final product concentrations ranged 
from 1–10 mM. The product concentration shown corresponds to the concentration in the reaction mixture; the 
final analytical sample is twofold diluted. 
Analysis was performed on an Agilent 1260 Infinity II HPLC instrument with water/acetonitrile mobile phase 
(1 mL min-1 flow), with an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a 
Poroshell 120 guard column (1.7 μm packing, 2.1×5 mm), injecting 5 μL. Detection was at 220 nm (4 nm 
bandwidth). The gradient program and retention times are given in Table S9 and Table S10, respectively. 
Table S9. HPLC gradient program for C–H insertion analysis 
Time (minutes) % Acetonitrile 
0.00 12 
1.00 12 
3.50 95 
4.00 95 
4.01 12 
5.00 12 
 
Table S10. HPLC retention times for C–H insertion analysis 
Compound Retention time (minutes) 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide 1.05 
2-Ethylbenzenesulfonamide 2.38 
Propiophenone 3.00 
2-Ethylbenzenesulfonyl azide 3.48 
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3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (5) calibration curve 
 
2-Ethylbenzenesulfonamide (6) calibration curve 
 
Chiral analysis 
Chiral analysis was performed by HPLC with a chiral stationary phase, using a Hewlett Packard Series 1100 
HPLC instrument with hexanes/2-propanol mobile phase (1 mL min-1 flow). 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (3) 
Analysis was performed with a Daicel Chiralcel OJ-H column, (5 μm packing, 4.6×250 mm), with an isocratic 
30% 2-propanol/70% hexanes mobile phase. The peak areas were analyzed at 235 nm (16 nm bandwidth). 
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Figure S5. Chiral HPLC trace of rac-3. 
 
 
Figure S6. Chiral HPLC trace of PsEFE MLHMM-catalyzed product 3. 
 
 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (5) 
Analysis was performed with a Daicel Chiralpak IB column (5 μm packing, 4.6×250 mm), with an isocratic 25% 
2-propanol/75% hexanes mobile phase. The peak areas were analyzed at 220 nm (16 nm bandwidth). 
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Figure S7. Chiral HPLC trace of rac-5. 
 
 
Figure S8. Chiral HPLC trace of PsEFE VMM-catalyzed product 5.  
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SPECTROSCOPIC DATA 
1H NMR spectrum of p-Toluenesulfonyl azide (2) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of p-Toluenesulfonyl azide (2)  
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Ethylbenzenesulfonyl chloride (S1) 
400 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Ethylbenzenesulfonyl azide (4) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 2-Ethylbenzenesulfonyl azide (4) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
500 MHz, CDCl3, 23 ° C 
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13C NMR spectrum of 2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 3-Methylbenzo[d]isothiazole 1,1-dioxide (S2) 
400 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Ethylbenzenesulfonamide (6) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 2-Ethylbenzenesulfonamide (6) 
125 MHz, CDCl3, 23 °C 
 
